Related Experiment Video
Updated: May 18, 2026
08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Immunomodulating options for liver transplant patients.
Ali Zarrinpar1, Ronald W Busuttil
1Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Expert Review of Clinical Immunology
|September 21, 2012
Summary
Liver transplant survival has improved due to better immunosuppression and care. This review covers current immunosuppressive drugs, strategies, and immune monitoring for liver transplant patients.
Area of Science:
- Hepatology
- Immunology
- Transplant Surgery
Background:
- Liver transplantation has evolved significantly, with improved outcomes attributed to advancements in immunosuppression and perioperative care.
- Cyclosporine, the first calcineurin inhibitor, marked a turning point, leading to a spectrum of immunosuppressive agents.
- Liver transplantation is now a highly successful treatment for end-stage liver disease.
Purpose of the Study:
- To review current immunosuppressive agents used in liver transplantation.
- To discuss tailored therapeutic strategies for specific patient populations.
- To highlight advances in immune monitoring and tolerance in liver transplant recipients.
Main Methods:
- Comprehensive literature review of immunosuppressive agents in liver transplantation.
- Analysis of perioperative and maintenance immunosuppression protocols.
- Examination of immune monitoring techniques and tolerance induction strategies.
Main Results:
- Modern immunosuppression includes calcineurin inhibitors, steroids, mTOR inhibitors, antimetabolites, and antibodies targeting T-cell activation.
- Therapeutic strategies are increasingly personalized based on patient factors and risk profiles.
- Advances in immune monitoring aid in optimizing immunosuppression and assessing tolerance.
Conclusions:
- Current immunosuppressive regimens and perioperative care have dramatically improved liver transplant outcomes.
- Personalized therapeutic strategies and advanced immune monitoring are key to successful long-term liver transplant management.
- Ongoing research focuses on achieving immune tolerance to reduce reliance on immunosuppression.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...